4.8 Article

Temperature-triggered on-demand drug release enabled by hydrogen-bonded multilayers of block copolymer micelles

Journal

JOURNAL OF CONTROLLED RELEASE
Volume 171, Issue 1, Pages 73-80

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.jconrel.2013.06.031

Keywords

Temperature responsive; Block copolymer micelles; Layer-by-layer; Drug release; Poly(N-isopropylacrylamide)

Funding

  1. National Science Foundation [DMR-0906474]
  2. National Institute of Arthritis and Musculoskeletal and Skin Diseases [1R21 AR056416]
  3. National Science Foundation through NSF [DMR-0922522]
  4. Division Of Materials Research
  5. Direct For Mathematical & Physical Scien [0906474] Funding Source: National Science Foundation

Ask authors/readers for more resources

We report on hydrogen-bonded layer-by-layer (LbL) films as a robust, reusable platform for temperature-triggered on-demand release of drugs. Films with high drug loading capacity, temperature-controlled on-off drug release, and stability at physiological conditions were enabled by assembly of tannic acid (TA) with temperature-responsive block copolymer micelles (BCMs), which were pre-formed by heating solutions of a neutral diblock copolymer, poly(N-vinylpyrrolidone)-b-poly(N-isopropylacrylamide) (PVPON-b-PNIPAM), to a temperature above the lower critical solution temperature (LCST) of PNIPAM. The BCM/TA films exhibited temperature-triggered swelling/deswelling transitions at physiological conditions (swelling ratios of 1.75 and 1.2 at 37 degrees C and 20 degrees C, respectively). A model drug, doxorubicin (DOX) was incorporated into the film at a high drug-to-matrix ratio (similar to 9.3 wt.% of DOX per film mass), with a total loading capacity controlled by the film thickness. At 37 degrees C, DOX was efficiently retained within the hydrophobic BCM cores of BCM/TA films, whereas exposure to a lower temperature (20 degrees C) triggered fast DOX release. While neither bare BCM-containing films nor films loaded with DOX showed cytotoxicity at 37 degrees C, drug released from films at lower temperature exhibited high potency against breast cancer cells. Repeated on/off drug release was demonstrated with 1.5-mu m-thick DOX-loaded films, allowing at least three 30-min cooling cycles with consistent DOX (similar to 12-16% of loaded DOX released for each cycle) released over a 4-day period. Despite significant stress associated with multiple swelling/deswelling cycles, films maintained their structural integrity in PBS, and each film could be repeatedly loaded with drug and used more than 15 times with only similar to 7% loss in film thickness and no obvious changes in reloading capacity or release profiles. This work presents the first proof-of-concept utility of temperature-responsive BCM-containing films for repeated on-demand release of a drug. (C) 2013 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available